Baytacare Pharmaceutical Co., Ltd. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2017. For the quarter, the company's turnover was RMB 8,917,000. Operating loss was RMB 2,444,000 compared to RMB 3,208,000 a year ago. Loss before taxation was RMB 2,950,000 compared to RMB 3,213,000 a year ago. Loss after taxation was RMB 2,950,000 compared to RMB 3,213,000 a year ago. Total comprehensive loss attributable to shareholders was RMB 2,950,000 compared to RMB 3,213,000 a year ago. Loss per share was RMB 0.4 compared to RMB 0.4 a year ago. For the six months, the company's turnover was RMB 15,094,000. Operating loss was RMB 9,151,000 compared to RMB 4,145,000 a year ago. Loss before taxation was RMB 9,758,000 compared to RMB 4,156,000 a year ago. Loss after taxation was RMB 9,758,000 compared to RMB 4,156,000 a year ago. Total comprehensive loss attributable to shareholders was RMB 9,758,000 compared to RMB 4,156,000 a year ago. Loss per share was RMB 1.1 compared to RMB 0.6 a year ago. Net cash outflow from operating activities was RMB 58,451,000 compared to RMB 74,000 a year ago.